Consanguineous hemolytic uremic syndrome secondary toEscherichia coli O157:H7 infection treated with aggressive therapeutic plasma exchange

2001 ◽  
Vol 16 (3) ◽  
pp. 155-156 ◽  
Author(s):  
Katharine A. Downes ◽  
Kathleen Allen ◽  
Ravindra Sarode ◽  
Roslyn Yomtovian
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Therapeutic Plasma Exchange ◽  
Uremic Syndrome

scholarly journals Pediatric Pneumococcal Hemolytic Uremic Syndrome Treated with Sequence Tandem Therapeutic Plasma Exchange and Continuous Venovenous Hemodiafiltration: A Case Report

2020 ◽  
Vol 10 (01) ◽  
pp. e221-e223
Author(s):  
Josko Markic ◽  
Branka Polic ◽  
Tanja Kovacevic ◽  
Marijana Rogulj ◽  
Tatjana Catipovic Ardalic
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Wide Spectrum ◽  
Pneumococcal Vaccination ◽  
Kidney Injury ◽  
Therapeutic Plasma Exchange ◽  
University Hospital ◽  
Course Of Illness ◽  
Continuous Venovenous Hemodiafiltration ◽  
Uremic Syndrome

AbstractHemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Approximately 5% of HUS cases are associated with Streptococcus pneumoniae infections (pHUS). Treatment includes supportive care with appropriate antimicrobial therapy, fluid and blood product resuscitation, and renal replacement therapy. We presented a case of a 22-month-old previously healthy girl, who was hospitalized at University Hospital of Split. Left-sided pneumonia and sepsis caused by S. pneumoniae were confirmed. The course of illness was complicated with development of pHUS. Since the pathogenesis of pHUS is only partially understood, the treatment remains controversial. Our patient was successfully treated with daily sequence tandem continuous venovenous hemodiafiltration and therapeutic plasma exchange with albumins, along with other supportive measures. Therefore, in our opinion, plasmapheresis should be considered as a part of standard treatment of children with pHUS. Additionally, the incidence of pHUS appears to be increasing. S. pneumoniae is a particularly important among pediatric pathogens and it can cause wide spectrum of illnesses. Therefore, due to the significant burden of invasive pneumococcal disease, pneumococcal vaccination should be encouraged.

Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: A case report

2012 ◽  
Vol 27 (4) ◽  
pp. 212-214 ◽  
Author(s):  
Melissa L. Petras ◽  
Nancy M. Dunbar ◽  
James J. Filiano ◽  
Matthew S. Braga ◽  
Michael C. Chobanian ◽  
...  
Keyword(s):  
Case Report ◽  
Streptococcus Pneumoniae ◽  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Therapeutic Plasma Exchange ◽  
Uremic Syndrome

Therapeutic Plasma Exchange in a Case of Cerebral Hemolytic Uremic Syndrome

2016 ◽  
Vol 3 (4) ◽  
pp. 215-216
Author(s):  
Gita Negi ◽  
Reshma Kaushik ◽  
Dushyant S Gaur ◽  
Shambhavi Tripathi
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Therapeutic Plasma Exchange ◽  
Uremic Syndrome

Successful therapeutic plasma exchange in a 3.2-kg body weight neonate with atypical hemolytic uremic syndrome

2011 ◽  
Vol 26 (3) ◽  
pp. 162-165 ◽  
Author(s):  
Sunkyung Jung ◽  
Eun-Suk Kang ◽  
Chang-Seok Ki ◽  
Dae-Won Kim ◽  
Kyung-Hoon Paik ◽  
...  
Keyword(s):  
Body Weight ◽  
Hemolytic Uremic Syndrome ◽  
Plasma Exchange ◽  
Atypical Hemolytic Uremic Syndrome ◽  
Therapeutic Plasma Exchange ◽  
Uremic Syndrome
Sign in / Sign up

Export Citation Format

Share Document